GlaxoSmithKline plc (GSK) is a global biopharmaceutical company headquartered in the United Kingdom. The company researches, develops, manufactures, and markets vaccines and specialty medicines, with core areas including infectious diseases, HIV (through majority-owned ViiV Healthcare), respiratory and immunology, and oncology. GSK operates extensive R&D programs and clinical development activities supported by a worldwide network of laboratories and regulatory engagements. In 2022, it demerged its consumer healthcare business into Haleon, focusing GSK on prescription medicines and vaccines.
For the chemical and life sciences value chain, GSK’s operations span small-molecule synthesis, biologics, and large-scale vaccine production, encompassing active pharmaceutical ingredient (API) and intermediate manufacturing for its own products, formulation, and fill-finish capabilities. The company maintains global manufacturing sites and supply chains adhering to GMP and other international quality standards, and collaborates with partners and institutions to advance new therapies and improve production reliability.
To provide comprehensive coverage, we aggregate data and news under the name GSK, encompassing the following company names, divisions, and related entities:
GlaxoSmithKline plc and GlaxoSmithKline.
This list encompasses current and former names, alternate names, and key divisions associated with GSK, ensuring you can easily find all relevant information under a single, unified profile.
